Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Zaman Huri, Hasniza ^a,b   Permalu, Vishaaliny ^a   Vethakkan, Shireene Ratna ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; INSULIN; ISOPHANE INSULIN; LOOP DIURETIC AGENT; NEUTRAL INSULIN; PREDNISOLONE;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; YOUNG ADULT; ACUTE DISEASE; COMPLICATION; DRUG ADMINISTRATION; MIDDLE AGED;

ACUTE DISEASE; ADULT; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84907452150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106505     Document Type: Article

References (15)

1. Mafauzy M, Hussein Z, Chan SP (2011) The status of diabetes control in Malaysia: Results of DiabCare 2008. The Medical Journal of Malaysia 66(3): 175-181.
2. Dombrowski NC, Karounos DG (2012) Pathophysiology and management strategies for hyperglycemia for patients with acute illness during and following a hospital stay. Metabolism. Retrieved October 20, 2012, from http://ezproxy.um.edu.my:2095/science/article/pii/S0026049512002831.
3. Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan NWZ (2013) Demographic and clinical predictors for insulin resistance in type 2 diabetes mellitus patients during severe/acute hyperglycemia phase. Latin American Journal of Pharmacy 32(1): 120-127.
4. Nau KC, Lorenzetti RC, Cucuzzella, Devine T, Kline J (2010) Glycemic control in hospitalized patients not in intensive care: Beyond sliding-scale insulin. American Family Physician 81(9): 1130-1135.
5. American Diabetes Association (2013) Standard of medical care in diabetes. Diabetes Care 36(1): S11-S66.
6. Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, et al. (2011) Randomised study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 34(2): 256-261.
7. Huri HZ, Yeap SM, Pendek R (2007) Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients. Asian Biomedicine, 1(3): 307-311.
8. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, et al. (2007) Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30(9): 2181-2186. (Pubitemid 47359011)
9. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 87(1): 4-14.
10. Magaji V, Johnston JM (2011) Inpatient management of hyperglycemia and diabetes. Clinical Diabetes 29(1): 3-9.
11. Bonora E, Muggeo M (2001) Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: The epidemiological evidence. Diabetologia 44(12): 2107-2114. (Pubitemid 34015463)
12. Lutfi MF, Sukkar MY (2011) The hyperglycemic effect of bronchial asthma. Suddan Medical Journal 47(2): 69-74.
13. Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. The Lancet 373(9677): 1798-1807.
14. Baldwin D, Apel J (2013) Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes. Current Diabestes Reports 13(1): 114-120.
15. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, et al. (2012) Management of hyperglycemia in hospitalized patients in non-critical care setting: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 97(1): 16-38. Malaysia